ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $480 | -93.1% | 100 | -89.3% | 0.00% | – |
Q2 2023 | $6,999 | +66.1% | 932 | 0.0% | 0.00% | – |
Q1 2023 | $4,213 | +273.8% | 932 | +832.0% | 0.00% | – |
Q4 2022 | $1,127 | +12.7% | 100 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 100 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -95.6% | 100 | -95.2% | 0.00% | – |
Q4 2021 | $45,000 | +542.9% | 2,100 | +2000.0% | 0.00% | – |
Q3 2021 | $7,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $715,272,000 | 67.97% |
Logos Global Management LP | 3,156,981 | $232,796,000 | 22.72% |
Vivo Capital, LLC | 4,220,048 | $311,186,000 | 10.94% |
Foresite Capital Management IV, LLC | 785,945 | $57,956,000 | 6.94% |
Foresite Capital Management V, LLC | 320,000 | $23,597,000 | 6.94% |
Board of Trustees of The Leland Stanford Junior University | 518,822 | $38,258,000 | 3.38% |
Cormorant Asset Management, LP | 881,770 | $65,022,000 | 1.45% |
Redmile Group, LLC | 978,600 | $72,162,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 130,351 | $9,612,000 | 0.74% |
Artal Group S.A. | 525,000 | $38,714,000 | 0.68% |